JUPITER NEUROSCIENCES, INC.
Datakwaliteit: 100%
JUNS
Nasdaq
Manufacturing
Chemicals
€ 0,40
▲
€ 0,02
(4,04%)
Marktkapitalisatie: 13,79 M
Prijs
€ 0,38
Marktkapitalisatie
13,79 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -5,41 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-1237,16%
Onder sectorgemiddelde (-53,47%)
ROIC-1007,19%
Net Margin-39662,77%
Op. Margin-40873,19%
Veiligheid
Debt / Equity
N/A
Current Ratio0,65
Interest Coverage-134,94
Waardering
PE (TTM)
-1,59
Onder sectorgemiddelde (-1,48)
P/B Ratio240,12
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,6 | -1,5 |
| P/B | 240,1 | 1,6 |
| ROE % | -1237,2 | -53,5 |
| Net Margin % | -39662,8 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q32025 | -€ 0,08 | -€ 0,07 | +12,5% |
| Q22025 | -€ 0,07 | -€ 0,07 | 0,0% |
| Q12025 | -€ 0,03 | -€ 0,05 | -66,7% |
| Q42024 | -€ 0,02 | -€ 0,05 | -150,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 21.796,0 | Net Income (TTM) | -8,64 M |
| ROE | -1237,16% | ROA | -264,19% |
| Gross Margin | 80,59% | Operating Margin | -40873,19% |
| Net Margin | -39662,77% | Free Cash Flow (TTM) | -5,41 M |
| ROIC | -1007,19% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,65 |
| Interest Coverage | -134,94 | Asset Turnover | 0,01 |
| Working Capital | -886.484 | Tangible Book Value | 57.417 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,59 | Forward P/E | N/A |
| P/B Ratio | 240,12 | P/S Ratio | 632,54 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -39,27% | ||
| Market Cap | 13,79 M | Enterprise Value | 13,79 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,25 | Revenue / Share | 0,00 |
| FCF / Share | -0,15 | OCF / Share | -0,15 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 62,62% |
| SBC-Adj. FCF | -8,20 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 21.796,0 | — |
| Net Income | -8,64 M | -2,44 M |
| EPS (Diluted) | -0,25 | -0,08 |
| Gross Profit | 17.565,0 | — |
| Operating Income | -8,91 M | -3,09 M |
| EBITDA | — | — |
| R&D Expenses | 2,09 M | 492.660,0 |
| SG&A Expenses | 6,84 M | — |
| D&A | — | — |
| Interest Expense | 66.020,0 | 248.366,0 |
| Income Tax | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 5,56 M | 6,20 M |
| Total Liabilities | 7,40 M | 2,03 M |
| Shareholders' Equity | -1,83 M | 4,17 M |
| Total Debt | — | — |
| Cash & Equivalents | — | — |
| Current Assets | 4,82 M | 4,65 M |
| Current Liabilities | 7,40 M | 2,01 M |
{"event":"ticker_viewed","properties":{"ticker":"JUNS","listing_kind":"stock","pathname":"/stocks/juns","exchange":"Nasdaq","country":"US"}}